Review of candidate vaccines for the prevention of Lassa fever
The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by this pathogen is mostly limited to the West African c...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Central Research Institute for Epidemiology
2021-05-01
|
| Series: | Вопросы вирусологии |
| Subjects: | |
| Online Access: | https://virusjour.crie.ru/jour/article/viewFile/493/308 |
| _version_ | 1797782283938168832 |
|---|---|
| author | O. D. Popova O. V. Zubkova T. A. Ozharovskaia D. I. Zrelkin D. V. Voronina I. V. Dolzhikova D. V. Shcheblyakov B. S. Naroditsky D. Yu. Logunov A. L. Gintsburg |
| author_facet | O. D. Popova O. V. Zubkova T. A. Ozharovskaia D. I. Zrelkin D. V. Voronina I. V. Dolzhikova D. V. Shcheblyakov B. S. Naroditsky D. Yu. Logunov A. L. Gintsburg |
| author_sort | O. D. Popova |
| collection | DOAJ |
| description | The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by this pathogen is mostly limited to the West African countries: Sierra Leone, Liberia, Guinea and Nigeria, imported cases have been historically documented in Europe, the United States of America (USA), Canada, Japan, and Israel [2]. In 2017, WHO included the Lassa virus in the list of priority pathogens in need of accelerated research, development of vaccines, therapeutic agents and diagnostic tools regarding infections they cause [3]. This review describes main technological platforms used for the development of vaccines for the prevention of Lassa fever. |
| first_indexed | 2024-03-13T00:08:48Z |
| format | Article |
| id | doaj.art-8712d4df58614c4692a44a0e8aff11f6 |
| institution | Directory Open Access Journal |
| issn | 0507-4088 2411-2097 |
| language | English |
| last_indexed | 2024-03-13T00:08:48Z |
| publishDate | 2021-05-01 |
| publisher | Central Research Institute for Epidemiology |
| record_format | Article |
| series | Вопросы вирусологии |
| spelling | doaj.art-8712d4df58614c4692a44a0e8aff11f62023-07-12T19:56:47ZengCentral Research Institute for EpidemiologyВопросы вирусологии0507-40882411-20972021-05-016629110210.36233/0507-4088-33376Review of candidate vaccines for the prevention of Lassa feverO. D. Popova0https://orcid.org/0000-0003-3248-1227O. V. Zubkova1https://orcid.org/0000-0001-7893-8419T. A. Ozharovskaia2https://orcid.org/0000-0001-7147-1553D. I. Zrelkin3https://orcid.org/0000-0003-0899-8357D. V. Voronina4https://orcid.org/0000-0001-6629-744XI. V. Dolzhikova5https://orcid.org/0000-0003-2548-6142D. V. Shcheblyakov6https://orcid.org/0000-0002-1289-3411B. S. Naroditsky7https://orcid.org/0000-0001-5522-8238D. Yu. Logunov8https://orcid.org/0000-0003-4035-6581A. L. Gintsburg9https://orcid.org/0000-0003-1769-5059FSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaFSBI «National Research Centre for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya» of the Ministry of Health of RussiaThe Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1]. Although expansion of Lassa fever caused by this pathogen is mostly limited to the West African countries: Sierra Leone, Liberia, Guinea and Nigeria, imported cases have been historically documented in Europe, the United States of America (USA), Canada, Japan, and Israel [2]. In 2017, WHO included the Lassa virus in the list of priority pathogens in need of accelerated research, development of vaccines, therapeutic agents and diagnostic tools regarding infections they cause [3]. This review describes main technological platforms used for the development of vaccines for the prevention of Lassa fever.https://virusjour.crie.ru/jour/article/viewFile/493/308lassa viruscandidate vaccinesrecombinant vaccinesrecombinant viral vectors |
| spellingShingle | O. D. Popova O. V. Zubkova T. A. Ozharovskaia D. I. Zrelkin D. V. Voronina I. V. Dolzhikova D. V. Shcheblyakov B. S. Naroditsky D. Yu. Logunov A. L. Gintsburg Review of candidate vaccines for the prevention of Lassa fever Вопросы вирусологии lassa virus candidate vaccines recombinant vaccines recombinant viral vectors |
| title | Review of candidate vaccines for the prevention of Lassa fever |
| title_full | Review of candidate vaccines for the prevention of Lassa fever |
| title_fullStr | Review of candidate vaccines for the prevention of Lassa fever |
| title_full_unstemmed | Review of candidate vaccines for the prevention of Lassa fever |
| title_short | Review of candidate vaccines for the prevention of Lassa fever |
| title_sort | review of candidate vaccines for the prevention of lassa fever |
| topic | lassa virus candidate vaccines recombinant vaccines recombinant viral vectors |
| url | https://virusjour.crie.ru/jour/article/viewFile/493/308 |
| work_keys_str_mv | AT odpopova reviewofcandidatevaccinesforthepreventionoflassafever AT ovzubkova reviewofcandidatevaccinesforthepreventionoflassafever AT taozharovskaia reviewofcandidatevaccinesforthepreventionoflassafever AT dizrelkin reviewofcandidatevaccinesforthepreventionoflassafever AT dvvoronina reviewofcandidatevaccinesforthepreventionoflassafever AT ivdolzhikova reviewofcandidatevaccinesforthepreventionoflassafever AT dvshcheblyakov reviewofcandidatevaccinesforthepreventionoflassafever AT bsnaroditsky reviewofcandidatevaccinesforthepreventionoflassafever AT dyulogunov reviewofcandidatevaccinesforthepreventionoflassafever AT algintsburg reviewofcandidatevaccinesforthepreventionoflassafever |